Black Rock Inc. Ascendis Pharma A/S Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Black Rock Inc. holds 405,989 shares of ASND stock, worth $59.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

405,989

Previous 405,169 0.2%

Holding current value

$59.1 Million

Previous $61.2 Million 9.6%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$121.07 - $153.67 $99,277 - $126,009	820 Added 0.2%	405,989 $55.4 Million
Q1 2024 May 10, 2024	BUY	$123.45 - $159.4 $6.93 Million - $8.95 Million	56,147 Added 16.09%	405,169 $61.2 Million
Q4 2023 Feb 13, 2024	BUY	$86.1 - $127.36 $1.33 Million - $1.97 Million	15,456 Added 4.63%	349,022 $44 Million
Q3 2023 Nov 13, 2023	SELL	$86.5 - $103.97 $2.38 Million - $2.86 Million	-27,524 Reduced 7.62%	333,566 $31.2 Million
Q2 2023 Aug 11, 2023	SELL	$69.96 - $97.84 $1.4 Million - $1.96 Million	-20,009 Reduced 5.25%	361,090 $32.2 Million
Q1 2023 May 12, 2023	SELL	$104.9 - $126.78 $1.43 Million - $1.73 Million	-13,671 Reduced 3.46%	381,099 $40.9 Million
Q4 2022 Feb 13, 2023	BUY	$99.42 - $131.97 $2.1 Million - $2.79 Million	21,146 Added 5.66%	394,770 $48.2 Million
Q3 2022 Nov 14, 2022	SELL	$84.03 - $110.23 $1.64 Million - $2.15 Million	-19,536 Reduced 4.97%	373,624 $38.6 Million
Q2 2022 Aug 12, 2022	SELL	$78.08 - $117.61 $618,705 - $931,941	-7,924 Reduced 1.98%	393,160 $36.5 Million
Q1 2022 May 12, 2022	BUY	$102.18 - $135.75 $8.28 Million - $11 Million	80,988 Added 25.3%	401,084 $47.1 Million
Q4 2021 Feb 10, 2022	SELL	$127.1 - $169.66 $2.41 Million - $3.22 Million	-18,980 Reduced 5.6%	320,096 $43.1 Million
Q3 2021 Nov 09, 2021	BUY	$112.67 - $176.92 $373,501 - $586,489	3,315 Added 0.99%	339,076 $54 Million
Q2 2021 Aug 11, 2021	BUY	$121.62 - $145.29 $40.8 Million - $48.8 Million	335,761 New	335,761 $44.2 Million

Others Institutions Holding ASND

# of Institutions

236

Shares Held

60.2M

Call Options Held

80.3K

Put Options Held

216K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $8.13B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account